ADMA Biologics, Inc.
Case Overview
Status: | Status: Investigating |
Company Name: | Company Name: ADMA Biologics, Inc. |
Ticker: | Ticker: ADMA |
Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
Related Practices: | Related Practices: Securities |
The law firm of Kirby McInerney LLP is investigating potential claims against ADMA Biologics, Inc. (“ADMA Biologics” or the “Company”) (NASDAQ: ADMA). The investigation concerns whether ADMA and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
On October 9, 2024, ADMA Biologics disclosed the surprise resignation of its independent outside auditor CohnReznick LLP. On this news, the price of ADMA Biologics shares declined by $3.72 per share from $20.33 per share on October 9, 2024, to close at $17.01 on October 10, 2024.
On October 9, 2024, ADMA Biologics disclosed the surprise resignation of its independent outside auditor CohnReznick LLP. On this news, the price of ADMA Biologics shares declined by $3.72 per share from $20.33 per share on October 9, 2024, to close at $17.01 on October 10, 2024.